JasonJianxunWangMD

Summary

• Jason is a Senior Associate on the Frazier Life Sciences team focused on identifying and evaluating new public investment opportunities.
  
  Prior to joining Frazier Life Sciences, Jason was a Principal at Vivo Capital. At Vivo, Jason evaluated public market biotech companies pursuing transformative treatments. In prior roles, Jason served on the business development team at Fortress Biotech, where he helped create new biotech companies including Hepla Sciences, which focuses on treating metabolic diseases.
  
  Jason attended medical school at the University of Illinois, where he was awarded an HHMI summer fellowship for basic science research. Jason earned his B.A. in Chemistry and History from the University of Rochester, where he spent two years in Robert Boeckman’s lab studying small molecules as oncology therapeutics.